|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, May 29, 2017 ) As per the syndicated report published by Market Data Forecast Europe Companion Diagnostics Market which is estimated to be USD 0.77 billion in 2016 is poised to reach USD 1.84 billion by 2021, at a CAGR of 19.05% from 2016 to 2021. It can attributed to the factors such as increasing prevalence of cancer and cardiac, neurological, and musculoskeletal disorders, rise in cognizance for prompt diagnosis, rising number of diagnostic imaging techniques and improving healthcare infrastructure in developing markets. However certain challenges like stringent government laws, improper facilities and lack in skilled personnel must be dealt with to attain the full potential.
To give a brief idea, companion diagnostic devices are those medical devices which provide information that is necessary for drug safety and effectives or any other biological product. This is helpful for the patients to determine merits derived from therapeutics products, its risks and side effects involved in it.
To give an idea in depth, companion diagnostic includes in-vitro diagnostic devices that are helpful to enhance the therapeutic treatment. These companion diagnostics have made systematic pharmacogenomic data in relation with drugs into the prescription labels so that it’s easy to understand and decide the most optimal treatment of the patient. Internationally, most of the industrialized nations are spending a huge part of their GDP on healthcare necessities. The US is set to devote almost 20% of its GDP on healthcare by 2017, a higher proportion than any other developed country.
For Full Report refer to: http://www.marketdataforecast.com/market-reports/europe-companion-diagnostics-market-642/
Europe Companion Diagnostics Market is segmented based on Indication and technology as mentioned below for attaining a more granular perspective of the market. In the report each sub-segment is provided with Market Size Estimations and Y-o-Y Forecasts.
Based on Indication:
• Oncology
o Colorectal Cancer
o Breast Cancer
o Lung Cancer
o Gastric Cancer
o Melanoma
• Inflammation and Autoimmune Diseases
• Cardiovascular Diseases
• Central Nervous System Disorders
• Virology Diseases
Based on Technology:
• Immuno Histochemistry
• Molecular Diagnostics
o In-Situ Hybridization
o Real Time PCR
o Gene Sequencing
Europe is an amalgamation of major economies like Germany, Spain, Italy, U.K. and France among others to name a few. The report justifies this by offering country wise data for the EU5 countries while taking some other predominant economies into consideration as well (Rest of Europe). As per the study, Germany is the fastest growing market in this region.
Free Sample for report: http://www.marketdataforecast.com/market-reports/europe-companion-diagnostics-market-642/request-sample
Bbott Molecular Inc., Roche Molecular Systems Inc., Leica Biosystems Nussloch GmbH, bioMérieux Inc., Dako Inc., Qiagen Ltd. And ARUP Laboratories, are the major players operating in the Europe Companion Diagnostic Market. Therefore, the competition among key players is increasing because of technological advancements and end-user preferences.
Enquire about the report:http://www.marketdataforecast.com/market-reports/europe-companion-diagnostics-market-642/inquire
The Europe Companion Diagnostics market report offers wide-range of scope:
• Regional and country-level analysis that provides an individual perspective of Asia-Pacific region and the aforementioned countries
• Know more about key areas of industry growth via detailed Segment-level analysis on basis of indication, technology, along with market size forecasts and y-o-y estimations
• Detailed explanation of major drivers, restraints, opportunities, and challenges (DROC) that affect the market and impact the ever-shifting market dynamics
• Strategic Analyses containing PESTLE and Porter’s Five Forces Analyses which are obtained by studying the macro & micro environmental factors that affect the market demographics
• Comprehensive listing of key market players along with Company overview, product portfolios, financials (subjected to availability), SWOT analysis and analyst overview
• Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
• Market Outlook - Investment opportunities devised by stand in experts to provide both individuals and organizations a strong financial foothold in the market
For more reports related to the Diagnostics Market:
Companion Diagnostics Market: http://www.marketdataforecast.com/market-reports/global-companion-diagnostics-market-640/
In-vitro Diagnostics Market: http://www.marketdataforecast.com/market-reports/global-in-vitro-diagnostics-market-146/
Preclinical In-vivo Imaging Market: http://www.marketdataforecast.com/market-reports/global-preclinical-in-vivo-imaging-market-582/
Nuclear Medicine Diagnostics Market: http://www.marketdataforecast.com/market-reports/global-nuclear-medicine-diagnostics-market-123/
Ultrasound Devices Market: http://www.marketdataforecast.com/market-reports/global-ultrasound-devices-market-575/
Buy now at: https://www.marketdataforecast.com/cart/buy-now/europe-companion-diagnostics-market-642
About Market Data Forecast:
The publisher of this report Market Data Forecast is well known for the services they render in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. Their research reports section offers a wide variety of market studies ranging from all-encompassing comprehensive market studies to product specific niche markets covering Europe among other regions of the global market as well, that too with competitive pricing options. For more info kindly visit, www.marketdataforecast.com
Market Data Forecast
Abhishek
+1-888- 702-9626
abhishek@marketdataforecast.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
